Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT05630027 Completed - Alopecia Clinical Trials

A Scalp Lotion Toimprove Sensitive Scalp Syndrome

Start date: January 2, 2019
Phase:
Study type: Observational

Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.

NCT ID: NCT05625672 Completed - Nurse's Role Clinical Trials

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

NCT ID: NCT05623826 Completed - Stress Clinical Trials

Feasibility and Efficacy of a Digital Training Intervention to Increase Reward Sensitivity- Imager

IMAGER
Start date: September 27, 2020
Phase: N/A
Study type: Interventional

Development and feasibility test of an Ecological Momentary Intervention (EMI) - Imager, to promote and improve stress resilience, specifically to increase reward sensitivity.

NCT ID: NCT05623761 Completed - Gingivitis Clinical Trials

Toothpastes With Thermal Water for Oral Health

Start date: November 1, 2022
Phase: Phase 4
Study type: Interventional

The aim of the study is to compare the effect of toothpastes containing thermal water of Castera-Verduzan with 1450 ppm fluoride and without fluorinated derivatives on oral hygiene, gingivitis, and dentin hypersensitivity in young adults.

NCT ID: NCT05607212 Completed - Muscle Weakness Clinical Trials

Lumbosacral Muscle Sensitivity & Pressure Pain Threshold After Kettlebell Swings

Start date: November 14, 2022
Phase: N/A
Study type: Interventional

The primary purpose of the study is to assess the muscle contractility and sensitivity of lumbar erector spinae, biceps femoris, and gluteus maximus short-term response to Tabata kettlebell swing protocol.

NCT ID: NCT05605444 Completed - Clinical trials for Osteoarthritis, Knee

The Effect of an Acute Bout of Exercise on Pain Sensitivity and Clinical Pain in Adults With Knee Osteoarthritis

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this interventional study is to investigate the effectiveness of an acute bout of exercises on pain sensitivity and clinical pain among adults with knee osteoarthritis. The following question will be answered in this research Q1: Is acute bout of exercise effective in reducing pain among adult with knee osteoarthritis? Participants who agree to participate and sign the informed consent will be randomised to one of three groups: Group 1: Isometric exercise with neutral language and no verbal suggestion consisting of 1 rep of wall squat, 3 min or to volitional fatigue at 100° knee angle;(n=30). Group 2: Isometric exercise with neutral language and no verbal suggestion consisting of 3 reps of wall squat, 3 min or to volitional fatigue at 100°degree knee angle, 30 sec rest between rep, ;(n=30). Group 3 (Control group): true control (do nothing);(n=30).

NCT ID: NCT05598606 Completed - Denosumab Allergy Clinical Trials

Denosumab vs Zoledronate After Vertebroplasty

Start date: January 12, 2021
Phase: Phase 4
Study type: Interventional

Osteoporotic vertebral compression fracture (OVCF) patients had a proportion of secondary fractures after percutaneous vertebroplasty (PVP). Denosumab and zoledronate acid is both effective to prevent bone loss for OVCF postmenopausal women. However, trial evidence comparing effect of denosumab vs zoledronate after PVP was unknown. The study aims to assess the efficiency of denosumab vs zoledronate for OVCF patients bone mineral density (BMD), bone turnover markers (BTMs), secondary fracture and adverse events after PVP.

NCT ID: NCT05588518 Completed - Clinical trials for Dental Root Sensitivity

Propolis as a Treatment for Cervical Dentin Hypersensitivity

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Fluoridated desensitizers the frequently used for the treatment of dentin hypersensitivity (DH) with Iontophoresis. This study aimed to evaluate and compare the immediate and long-term effects of 10% Propolis with 2% sodium fluoride and 1.23% acidulated phosphate fluoride when applied along with Iontophoresis for the treatment of cervical dentin hypersensitivity (DH). Single-center, parallel, and double-blinded randomized clinical trials were conducted on systemically healthy patients, complaining about DH, with at least two sites. 10% propolis, 2% Sodium Fluoride and 1.23% Acidulated Phosphate Fluoride were used as desensitizers along with the Iontophoresis. After applying specific stimuli any decrease in DH was measured at baseline before and after application, on the 14th day after use, and at 28th-day post-intervention time intervals.

NCT ID: NCT05582304 Completed - Visual Acuity Clinical Trials

Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.

NCT ID: NCT05562661 Completed - Rosacea Clinical Trials

M89PF in Rosacea Associated With Erythema and Sensitive Skin

Start date: January 2, 2021
Phase:
Study type: Observational

Rosacea is a common facial dermatosis, with flares induced by exposome factors. M89PF containing Vichy mineralizing water, probiotic fractions, hyaluronic acid, niacinamide and tocopherol repairs the skin barrier and reinforces skin defences against exposome factors. This study assessed the benefit of M89PF in patients with rosacea associated with erythema and sensitive skin during the Covid-19 pandemic with use of protective face masks.